Frédéric Legrand
Impact in
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
-
- Immune Cell Function and Interaction
Papers in
-
- Sarcoma Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Prostate Cancer Treatment and Research 1
- Renal cell carcinoma treatment 1
- Surgery 4
- Co-authors
- Maurizio Aricò (1 shared paper)Carmela Fusco (1 shared paper)Cesare Danesino (1 shared paper)Gritta Janka (1 shared paper)Rita Clementi (1 shared paper)Valentino Conter (1 shared paper)Sylvie Chevret (6 shared papers)Esma Saâda-Bouzid (3 shared papers)
- Journals
- Annals of Oncology (5 papers)Journal of Clinical Oncology (3 papers)Circulation Cardiovascular Imaging (1 paper)Targeted Oncology (1 paper)PLoS ONE (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Frédéric Legrand
13 papers receiving 178 citations
Peers
Comparison fields: 5 of 40
- Hematology 62
- Immunology 52
- Oncology 50
- Infectious Diseases 33
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Frédéric Legrand
This map shows the geographic impact of Frédéric Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Legrand more than expected).
Fields of papers citing papers by Frédéric Legrand
This network shows the impact of papers produced by Frédéric Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Legrand. The network helps show where Frédéric Legrand may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Legrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Familial hemophagocytic lymphohistiocytosis: how late can the onset be? | 2001 | 65 |
| 2 | 2020 | 23 | |
| 3 | 2021 | 20 | |
| 4 | 2021 | 20 | |
| 5 | 2020 | 14 | |
| 6 | 2020 | 10 | |
| 7 | 2014 | 9 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 7 | |
| 10 | 2010 | 5 | |
| 11 | 2023 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 0 |
About Frédéric Legrand
Frédéric Legrand is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 14 papers that have together received 184 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers), Genetic factors in colorectal cancer (2 papers), Aerospace and Aviation Technology (1 paper), Prostate Cancer Treatment and Research (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Hematology (62 citations), Immunology (52 citations), Oncology (50 citations), Infectious Diseases (33 citations) and Pulmonary and Respiratory Medicine (54 citations). Frédéric Legrand has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Maurizio Aricò, Carmela Fusco, Cesare Danesino, Gritta Janka, Rita Clementi, Valentino Conter, Sylvie Chevret, Esma Saâda-Bouzid, Natalie Hoog-Labouret and C. Chong-Nguyen. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Circulation Cardiovascular Imaging, Targeted Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.